See up to 3 months of ICAD. The 7-day demo opens the 1M and 3M ranges and puts ICAD on your watchlist.
Start 7-day demoLatest ICAD insider trades
About ICAD INC (ICAD)
ICAD INC files with the SEC under CIK 0000749660 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
ICAD Form 4 activity by transaction type, last 90 days
No Form 4 activity for ICAD in the last 90 days.
ICAD insider transactions (Form 4)
748 Form 4 filings on record, the earliest from Jul 17, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Hedvig Hricak - Director | Derivative | Stock Option (right to buy) | 40,000 | - | - | |
| Hedvig Hricak - Director | Derivative | Stock Option (right to buy) | 5,415 | - | - | |
| Hedvig Hricak - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Hedvig Hricak - Director | Derivative | Stock Option (right to buy) | 6,641 | - | - | |
| Michael John Doyle - Director | Derivative | Common Stock | 52 | - | - | |
| Michael John Doyle - Director | Derivative | Stock Option (right to buy) | 40,000 | - | - | |
| Michael John Doyle - Director | Derivative | Stock Option (right to buy) | 9,874 | - | - | |
| Michael John Doyle - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Michael John Doyle - Director | Derivative | Stock Option (right to buy) | 7,482 | - | - | |
| Eric Lonnqvist - Officer | Derivative | Common Stock | 8,488 | - | - | |
| Eric Lonnqvist - Officer | Derivative | Stock Option (right to buy) | 10,000 | - | - | |
| Eric Lonnqvist - Officer | Derivative | Stock Option (right to buy) | 15,000 | - | - | |
| Eric Lonnqvist - Officer | Derivative | Stock Option (right to buy) | 100,000 | - | - | |
| Eric Lonnqvist - Officer | Derivative | Stock Option (right to buy) | 25,000 | - | - | |
| Dana R. Brown - Officer | Derivative | Common Stock | 54,350 | - | - | |
| Dana R. Brown - Officer | Derivative | Stock Option (right to buy) | 40,000 | - | - | |
| Dana R. Brown - Officer | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Dana R. Brown - Officer | Derivative | Stock Option (right to buy) | 45,000 | - | - | |
| Dana R. Brown - Officer | Derivative | Stock Option (right to buy) | 250,000 | - | - | |
| Dana R. Brown - Officer | Derivative | Stock Option (right to buy) | 100,000 | - | - | |
| Rakesh Patel - Director | Derivative | Common Stock | 62,217 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 40,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 8,315 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 3,452 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 2,304 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 11,361 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 22,154 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 24,194 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Rakesh Patel - Director | Derivative | Stock Option (right to buy) | 8,575 | - | - | |
| Susan Alyson Wood - Director | Derivative | Common Stock | 4,134 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 40,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 8,738 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 3,879 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 2,590 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 13,137 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 13,044 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Susan Alyson Wood - Director | Derivative | Stock Option (right to buy) | 10,593 | - | - | |
| Andy Sassine - Director | Derivative | Common Stock | 1,198,382 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 6,219 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 6,517 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 9,321 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 4,002 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 2,672 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 28,774 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 12,954 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 34,706 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,265 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 22,259 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 27,586 | - | - | |
| Andy Sassine - Director | Derivative | Stock Option (right to buy) | 30,000 | - | - | |
| Jonathan Go - Officer | Derivative | Common Stock | 188,725 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 25,000 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 4,951 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 14,183 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 3,286 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 21,000 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 19,000 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 25,000 | - | - | |
| Jonathan Go - Officer | Derivative | Stock Option (right to buy) | 50,000 | - | - |
ICAD insider trading FAQ
What is the latest insider trade for ICAD?
ICAD INC (ICAD) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-17. The full record for ICAD runs to 8 Form 4 filings, the earliest from 2025-07-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ICAD stock?
No insider purchases of ICAD were filed in the last 90 days.
How many insiders are selling ICAD stock?
No insider sales of ICAD were filed in the last 90 days.
Where can I see ICAD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ICAD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Hedvig Hricak view on EDGAR
- - Michael John Doyle view on EDGAR
- - Eric Lonnqvist view on EDGAR
- - Dana R. Brown view on EDGAR
- - Rakesh Patel view on EDGAR
- - Susan Alyson Wood view on EDGAR
- - Andy Sassine view on EDGAR
- - Jonathan Go view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ICAD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ICAD with a 7-day demo
- ICAD on your watchlist
- Every ICAD Form 4 filing on record
- Up to 3 months of ICAD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
